What medication compliance factors do you stress with patients who are on CD/LD and what compliance shortfalls—and variable responses to CD/LD—have you witnessed that provide rationale for using the CD/LD fractionable dosing formulation?

What medication compliance factors do you stress with patients who are on CD/LD and what compliance shortfalls—and variable responses to CD/LD—have you witnessed that provide rationale for using the CD/LD fractionable dosing formulation?

What medication compliance factors do you stress with patients who are on CD/LD and what compliance shortfalls—and variable responses to CD/LD—have you witnessed that provide rationale for using the CD/LD fractionable dosing formulation?


Created by

CMEducation Resources iQ&A Parkinson’s Disease (PD) Medical Intelligence Zone

Related Presenters

Laxman Bahroo, DO, FAAN

Laxman Bahroo, DO, FAAN

Associate Professor, Department of Neurology Georgetown University Medical Center Vice Chair of Finance Director, Residency Program Director, Botulinum Toxin Clinic Associate Professor of Neurology Medstar Georgetown University HospitalWashington, D.C.